90 related articles for article (PubMed ID: 9591786)
21. [Control of cell cycle by the p27 Cdk-inhibitor].
Toyoshima H
Tanpakushitsu Kakusan Koso; 1996 Sep; 41(12 Suppl):1732-6. PubMed ID: 8890630
[No Abstract] [Full Text] [Related]
22. p27KIP1, an inhibitor of cyclin-dependent kinases.
Koff A; Polyak K
Prog Cell Cycle Res; 1995; 1():141-7. PubMed ID: 9552359
[TBL] [Abstract][Full Text] [Related]
23. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2.
Soucek T; Yeung RS; Hengstschläger M
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15653-8. PubMed ID: 9861025
[TBL] [Abstract][Full Text] [Related]
24. Ectopic expression of cyclin D1 but not cyclin E induces anchorage-independent cell cycle progression.
Resnitzky D
Mol Cell Biol; 1997 Sep; 17(9):5640-7. PubMed ID: 9271439
[TBL] [Abstract][Full Text] [Related]
25. [Studies on the changes in calcium fluxes in ts-RSV LA 90 cells transformation].
Zhang Y; Wang DS; Zheng DD; Zhang HQ; Xue SB
Shi Yan Sheng Wu Xue Bao; 1990 Sep; 23(3):333-40. PubMed ID: 1965388
[TBL] [Abstract][Full Text] [Related]
26. Activated Src abrogates the Myc requirement for the G0/G1 transition but not for the G1/S transition.
Prathapam T; Tegen S; Oskarsson T; Trumpp A; Martin GS
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2695-700. PubMed ID: 16477001
[TBL] [Abstract][Full Text] [Related]
27. Chemical genetic blockade of transformation reveals dependence on aberrant oncogenic signaling.
Fan QW; Zhang C; Shokat KM; Weiss WA
Curr Biol; 2002 Aug; 12(16):1386-94. PubMed ID: 12194819
[TBL] [Abstract][Full Text] [Related]
28. Reversal of transformed phenotypes by herbimycin A in src oncogene expressed rat fibroblasts.
Murakami Y; Mizuno S; Hori M; Uehara Y
Cancer Res; 1988 Mar; 48(6):1587-90. PubMed ID: 3345529
[TBL] [Abstract][Full Text] [Related]
29. Confluence-induced cell cycle exit involves pre-mitotic CDK inhibition by p27(Kip1) and cyclin D1 downregulation.
Chassot AA; Lossaint G; Turchi L; Meneguzzi G; Fisher D; Ponzio G; Dulic V
Cell Cycle; 2008 Jul; 7(13):2038-46. PubMed ID: 18604165
[TBL] [Abstract][Full Text] [Related]
30. P27 in cell cycle control and cancer.
Møller MB
Leuk Lymphoma; 2000 Sep; 39(1-2):19-27. PubMed ID: 10975380
[TBL] [Abstract][Full Text] [Related]
31. v-Src generates a p53-independent apoptotic signal.
Webb BL; Jimenez E; Martin GS
Mol Cell Biol; 2000 Dec; 20(24):9271-80. PubMed ID: 11094078
[TBL] [Abstract][Full Text] [Related]
32. Role of Gas1 down-regulation in mitogenic stimulation of quiescent NIH3T3 cells by v-Src.
Grossi M; La Rocca SA; Pierluigi G; Vannucchi S; Ruaro EM; Schneider C; Tatò F
Oncogene; 1998 Oct; 17(13):1629-38. PubMed ID: 9796692
[TBL] [Abstract][Full Text] [Related]
33. Deregulated degradation of the cdk inhibitor p27 and malignant transformation.
Bloom J; Pagano M
Semin Cancer Biol; 2003 Feb; 13(1):41-7. PubMed ID: 12507555
[TBL] [Abstract][Full Text] [Related]
34. Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells.
Liu JJ; Chao JR; Jiang MC; Ng SY; Yen JJ; Yang-Yen HF
Mol Cell Biol; 1995 Jul; 15(7):3654-63. PubMed ID: 7791772
[TBL] [Abstract][Full Text] [Related]
35. Serum factors and v-src control two complementary mitogenic pathways in quail neuroretinal cells in culture.
Gillet G; Michel D; Crisanti P; Guérin M; Herault Y; Pessac B; Calothy G; Brun G; Volovitch M
Oncogene; 1993 Mar; 8(3):565-74. PubMed ID: 8437841
[TBL] [Abstract][Full Text] [Related]
36. Combination gene delivery of the cell cycle inhibitor p27 with thymidine kinase enhances prodrug cytotoxicity.
Danthinne X; Aoki K; Kurachi AL; Nabel GJ; Nabel EG
J Virol; 1998 Nov; 72(11):9201-7. PubMed ID: 9765467
[TBL] [Abstract][Full Text] [Related]
37. [G1-cyclin/Cdk and cancer].
Takahashi H; Matsushime H
Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1554-61. PubMed ID: 9279081
[No Abstract] [Full Text] [Related]
38. p27 Kip1 inhibits HER2/neu-mediated cell growth and tumorigenesis.
Yang HY; Shao R; Hung MC; Lee MH
Oncogene; 2001 Jun; 20(28):3695-702. PubMed ID: 11439332
[TBL] [Abstract][Full Text] [Related]
39. Differences in calmodulin levels of normal and transformed cells as determined by culture conditions.
Veigl ML; Vanaman TC; Branch ME; Sedwick WD
Cancer Res; 1984 Aug; 44(8):3184-9. PubMed ID: 6331640
[TBL] [Abstract][Full Text] [Related]
40. [G1 phase control by Cdk inhibitor].
Nakanishi M
Tanpakushitsu Kakusan Koso; 1996 Jun; 41(7):897-907. PubMed ID: 8966219
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
